Quantum Financial Partners LLC lowered its stake in shares of T. Rowe Price Capital Appreciation Equity ETF (NYSEARCA:TCAF – Free Report) by 20.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,130 shares of the company’s stock after selling 12,019 shares during the quarter. T. Rowe Price Capital Appreciation Equity ETF comprises approximately 1.0% of Quantum Financial Partners LLC’s investment portfolio, making the stock its 26th biggest position. Quantum Financial Partners LLC’s holdings in T. Rowe Price Capital Appreciation Equity ETF were worth $1,992,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the business. IFP Advisors Inc boosted its stake in shares of T. Rowe Price Capital Appreciation Equity ETF by 1.5% in the 3rd quarter. IFP Advisors Inc now owns 205,708 shares of the company’s stock valued at $8,695,000 after purchasing an additional 3,029 shares in the last quarter. Carroll Advisory Group LLC acquired a new stake in T. Rowe Price Capital Appreciation Equity ETF in the third quarter valued at approximately $416,000. Sard Wealth Management Group LLC grew its stake in shares of T. Rowe Price Capital Appreciation Equity ETF by 2.8% during the third quarter. Sard Wealth Management Group LLC now owns 67,441 shares of the company’s stock worth $2,851,000 after buying an additional 1,822 shares during the last quarter. ARS Wealth Advisors Group LLC grew its stake in shares of T. Rowe Price Capital Appreciation Equity ETF by 5.4% during the third quarter. ARS Wealth Advisors Group LLC now owns 472,881 shares of the company’s stock worth $19,989,000 after buying an additional 24,190 shares during the last quarter. Finally, Chemistry Wealth Management LLC boosted its holdings in shares of T. Rowe Price Capital Appreciation Equity ETF by 3.5% during the 3rd quarter. Chemistry Wealth Management LLC now owns 201,000 shares of the company’s stock valued at $8,496,000 after acquiring an additional 6,752 shares in the last quarter.
T. Rowe Price Capital Appreciation Equity ETF Stock Up 0.6%
T. Rowe Price Capital Appreciation Equity ETF stock traded up $0.25 during trading hours on Monday, hitting $43.27. The stock had a trading volume of 158,733 shares, compared to its average volume of 728,256. The stock has a market cap of $9.07 billion, a price-to-earnings ratio of 29.44 and a beta of 0.94. T. Rowe Price Capital Appreciation Equity ETF has a one year low of $34.43 and a one year high of $43.67. The business’s 50 day simple moving average is $42.72 and its 200-day simple moving average is $41.01.
T. Rowe Price Capital Appreciation Equity ETF Profile
The T. Rowe Price Capital Appreciation Equity ETF (TCAF) is an exchange-traded fund. The fund’s investment portfolio concentrates primarily on large cap equity. TCAF is an actively managed fund that pursues higher quality stocks of US large-cap companies that are perceived to have above average potential for capital growth.
See Also
- Five stocks we like better than T. Rowe Price Capital Appreciation Equity ETF
- Mr. Wonderful’s Test for AI Data Center Stocks: Power, Permits, and Tenants
- Alcoa Beat Earnings, But Can It Escape the Aluminum Bears?
- Insider Buying Is Rising at These 3 Regional Banks, But the Details Matter
- Illinois Tool Works Faces Headwinds—2 Alternatives Stand Out
Want to see what other hedge funds are holding TCAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for T. Rowe Price Capital Appreciation Equity ETF (NYSEARCA:TCAF – Free Report).
Receive News & Ratings for T. Rowe Price Capital Appreciation Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T. Rowe Price Capital Appreciation Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
